Profile
Infectious Diseases in the Crosshairs
A new translational-research center being built in Jena, Germany, aims to speed the path from lab to clinic for promising biophotonic technologies.
Artist’s rendering of the planned LPI building in Jena, Germany. [Image: Leibniz Institute of Photonic Technology]
As 2020 drew to a close, news on the COVID-19 front was decidedly mixed. The world was grappling with a second wave—or, in some societies, a third wave—of coronavirus infections, and facing the prospect of a tough 2021 first quarter. Yet the sudden news in November of very promising results in trials of COVID-19 vaccines raised hopes of gradually gaining the upper hand on the virus over the course of the year.
…Log in or become a member to view the full text of this article.
This article may be available for purchase via the search at Optica Publishing Group.
Optica Members get the full text of Optics & Photonics News, plus a variety of other member benefits.